Schley, Katharina
Friedrich, Josephine
Pilz, Andreas
Huang, Liping
Balkaran, Bridget L.
Maculaitis, Martine C.
Malerczyk, Claudius
Article History
Received: 24 December 2022
Accepted: 20 February 2023
First Online: 7 March 2023
Declarations
:
: The authors affirm that the research study was conducted in accordance with the Declaration of Helsinki of the World Medical Association. The study was granted an exemption determination by Sterling IRB (Atlanta, GA, US) on July 9, 2020 (IRB ID: 8176-JKen-Opurum) based on US 45 CFR ยง46.104(d). All participants provided their informed consent prior to participating in this study.
: Not applicable.
: This study was conducted under a research contract between Pfizer Inc. and Cerner Enviza and the study was funded by Pfizer Inc. KS and JF are employees of Pfizer Pharma GmbH and may own stocks or stock options. AP is an employee of Pfizer Corporation Austria Gesellschaft m.b.H. and may own stocks or stock options. LH is an employee of Pfizer Inc. and may own stocks or stock options. BLB and MCM are employees of Cerner Enviza. CM is an employee of Pfizer Pharma GmbH and may own stocks or stock options.